XPOVIO™ (selinexor) Available for Order at Biologics by McKesson
FDA-approved drug is new treatment option for patients with relapsed or penta-refractory multiple myeloma CARY, N.C., July 8, 2019—Biologics by […]
FDA-approved drug is new treatment option for patients with relapsed or penta-refractory multiple myeloma CARY, N.C., July 8, 2019—Biologics by […]